GENE logo

Genetic Technologies Limited (GENE) Accounts Receivable

Annual Accounts Receivable

$139.90 K
+$12.90 K+10.16%

01 June 2024

GENE Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Receivable

$139.90 K
-$620.10 K-81.59%

01 June 2024

GENE Quarterly Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GENE Accounts Receivable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.2%+10.2%
3 y3 years+108.2%+108.2%
5 y5 years+1106.0%+1106.0%

GENE Accounts Receivable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-54.0%+108.2%-93.0%+108.2%
5 y5 years-54.0%+1106.0%-93.0%+1106.0%
alltimeall time-90.8%+1716.9%-93.0%+1716.9%

Genetic Technologies Limited Accounts Receivable History

DateAnnualQuarterly
June 2024
$139.90 K(+10.2%)
$139.90 K(-81.6%)
Dec 2023
-
$760.00 K(+498.4%)
June 2023
$127.00 K(-58.3%)
$127.00 K(-93.6%)
Dec 2022
-
$1.99 M(+555.5%)
June 2022
$304.20 K(+352.7%)
$304.20 K(-84.5%)
Dec 2021
-
$1.96 M(+2820.8%)
June 2021
$67.20 K(+151.7%)
$67.20 K(-93.3%)
Dec 2020
-
$1.01 M(+3667.8%)
June 2020
$26.70 K(+130.2%)
$26.70 K(-91.3%)
Dec 2019
-
$308.20 K(+2556.9%)
June 2019
$11.60 K(+50.6%)
$11.60 K(-96.6%)
Dec 2018
-
$339.00 K(+4302.6%)
June 2018
$7700.00(-95.0%)
$7700.00(-97.2%)
Dec 2017
-
$275.20 K(+78.4%)
June 2017
$154.30 K(-47.4%)
$154.30 K(-70.9%)
Dec 2016
-
$530.70 K(+81.1%)
June 2016
$293.10 K(-27.2%)
$293.10 K(-40.9%)
Dec 2015
-
$495.90 K(+23.2%)
DateAnnualQuarterly
June 2015
$402.40 K(-52.3%)
$402.40 K(-44.5%)
Dec 2014
-
$724.80 K(-14.0%)
June 2014
$843.10 K(+203.5%)
$843.10 K(+76.2%)
Dec 2013
-
$478.40 K(+72.2%)
June 2013
$277.80 K(-28.3%)
$277.80 K(-28.3%)
June 2012
$387.30 K(-45.2%)
$387.30 K(-45.2%)
June 2011
$706.90 K(+11.4%)
$706.90 K(+11.4%)
June 2010
$634.70 K(-56.9%)
$634.70 K(-56.9%)
June 2009
$1.47 M(-3.6%)
$1.47 M(-3.6%)
June 2008
$1.53 M(+229.7%)
$1.53 M(+17.6%)
Dec 2007
-
$1.30 M(+180.3%)
June 2007
$463.80 K(-48.0%)
$463.80 K(-57.8%)
Dec 2006
-
$1.10 M(+23.2%)
June 2006
$892.20 K(+133.6%)
$892.20 K(+59.8%)
Dec 2005
-
$558.30 K(+46.2%)
June 2005
$382.00 K(+57.4%)
$382.00 K(+15.2%)
Dec 2004
-
$331.70 K
June 2004
$242.70 K(+60.1%)
-
June 2003
$151.60 K
-

FAQ

  • What is Genetic Technologies Limited annual accounts receivable?
  • What is the all time high annual accounts receivable for Genetic Technologies Limited?
  • What is Genetic Technologies Limited annual accounts receivable year-on-year change?
  • What is Genetic Technologies Limited quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Genetic Technologies Limited?
  • What is Genetic Technologies Limited quarterly accounts receivable year-on-year change?

What is Genetic Technologies Limited annual accounts receivable?

The current annual accounts receivable of GENE is $139.90 K

What is the all time high annual accounts receivable for Genetic Technologies Limited?

Genetic Technologies Limited all-time high annual accounts receivable is $1.53 M

What is Genetic Technologies Limited annual accounts receivable year-on-year change?

Over the past year, GENE annual accounts receivable has changed by +$12.90 K (+10.16%)

What is Genetic Technologies Limited quarterly accounts receivable?

The current quarterly accounts receivable of GENE is $139.90 K

What is the all time high quarterly accounts receivable for Genetic Technologies Limited?

Genetic Technologies Limited all-time high quarterly accounts receivable is $1.99 M

What is Genetic Technologies Limited quarterly accounts receivable year-on-year change?

Over the past year, GENE quarterly accounts receivable has changed by +$12.90 K (+10.16%)